Decreased calcineurin activity in circulation of Duchenne muscular dystrophy

Clinical Biochemistry

Volumn 40, Issue 7, 2007, Pages 443-446

  Sundaram, J Shanmuga ^a   Rao, V Mohana ^a   Meena, A K ^b   Anandaraj, M P J S ^a  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Activity; Calcineurin; DMD; Lymphocytes; Serum

Indexed keywords

4 NITROPHENOL; CALCINEURIN; TRIFLUOPERAZINE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; CALCINEURIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LYMPHOCYTES; MALE; MALONDIALDEHYDE; MUSCULAR DYSTROPHY, DUCHENNE; SUPEROXIDE DISMUTASE;

EID: 33947721591     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.01.006     Document Type: Article

References (25)

1. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58 (1989) 453-508
2. Rusnak F., and Mertz P. Calcineurin: form and function. Physiol. Rev. 80 (2000) 1483-1521
3. Crabtree G.R. Calcium, calcineurin, and the control of transcription. J. Biol. Chem. 276 (2001) 2313-2316
4. Bodensteiner J.B., and Engel A.G. Intracellular calcium accumulation in Duchenne muscular dystrophy and other myopathies: a study of 567,000 muscle fibres in 114 biopsies. Neurology 28 (1978) 439-446
5. Yarom R., Meyer S., More R., Liebergalt M., and Elder A. Platelet abnormalities in muscular dystrophy. Thromb. Haemost. 49 (1983) 168-172
6. Lechi C., Sinigaglia D., Guzzo P., Bonadonna G., and Zatti M. Platelet intracellular calcium in patients with Duchenne muscular dystrophy. Clin. Chim. Acta 177 (1988) 119-121
7. Dise C.A., Goodman D.B.P., Lake W.C., Hodson A., and Rasmussen H. Enhanced sensitivity to calcium in Duchenne muscular dystrophy. Biochem. Biophys Res. Commun. 79 (1977) 1286-1292
8. Nicholson G.A., and Sugars J. Decreased A 23187 induced chemiluminescence in Duchenne muscular dystrophy granulocytes. J. Neurol. Sci. 56 (1982) 11-16
9. 2+ metabolism in Duchenne muscular dystrophy: effects on cellular and viral growth. Proc. Natal. Acad. Sci. U. S. A. 81 (1984) 7617-7621
10. Jagadeesh G., Shailaja B., Lavanya M., Kusuma Kumari C., Anjaneyulu A., and Anandaraj M.P.J.S. Importance of monitoring calcium and calcium related properties in carrier detection for Duchenne muscular dystrophy. Ind. J. Med. Res. 99 (1994) 283-288
11. Hussain T., Narayan Kumar D.V., Sundaran C., Mohandas S., and Anandaraj M.P.J.S. Quantitative ELISA for platelet m-calpain: a phenotypic index for detection of carriers of Duchenne muscular dystrophy. Clin. Chim. Acta 269 (1998) 13-20
12. Jagadeesh G., Lavanya M., Anandaraj M.P.J.S., and Anjaneyulu A. Altered protein kinase C and protein kinase A activities in erythrocyte membrane, platelets and lymphocytes of Duchenne muscular dystrophy (DMD) patients. Clin. Chim. Acta 193 (1990) 79-84
13. Wilkins B.J., and Molkentin J.D. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res. Commun. 322 (2004) 1178-1191
14. Padma S., and Subramanyam C. Extracellular calcineurin: identification and quantitation in serum and amniotic fluid. Clin. Biochem. 32 (1999) 491-495
15. Chamberlain J.S., Gibbs R.A., Rainer J.E., Nguyen P.N., and Caskey C.T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 16 (1988) 11141-11156
16. Beggs A.H., Koenig M., Boyce F.M., and Kunkel L.M. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum. Genet. 86 (1990) 45-48
17. Kalofoutis A., Nicolaidou-Politis V., and Bouloukas A. Significance of lymphocyte fatty acid changes in chronic renal failure. Nephron 73 (1996) 704-706
18. Oberley L.W., and Li Y. Simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988) 501-504
19. Sadasivudu B., Sashikala M., Sailaja V., and Surender Reddy S. Serum malondialdehyde, insulin, glucose and lipid profile in hypertension. Med. Sci. Res. 25 (1997) 631-633
20. Namgaladze D., Hofer H.W., and Ullrich V. Redox control of calcineurin by targeting the binuclear Fe(2+)-Zn(2+) center at the enzyme active site. J. Biol. Chem. 277 (2002) 5962-5969
21. Petrof B.J. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am. J. Phys. Med. Rehabil. 81 (2002) S162-S174
22. Ian M., Hunter S., Brzeski M.S., and de Vane P.J. Superoxide dismutase, glutathione peroxidase and thiobabituric acid-reactive compounds in erythrocytes in Duchenne muscular dystrophy. Clin. Chim. Acta 115 (1981) 93-98
23. Fisher I., Abraham D., Bouri K., Hoffman Eric P., Muntoni F., and Morgan J. Prednisolone-induced changes in dystrophic skeletal muscle. FASEB J. 19 (2005) 834-836
24. Chakkalakal J.V., Harrison M.A., Carbonetto S., Chin E., Michel R.N., and Jasmin B.J. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum. Mol. Genet. 13 (2004) 379-388
25. Reiter T.A., and Rusnak F. Is calcineurin a peroxide-specific sensor in T-lymphocytes?. J. Biol. Inorg Chem. 7 (2002) 823-834